MNOV
MediciNova, Inc.NASDAQ
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • marketchameleon.com | Send Message 12 Oct

    $MNOV Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Amyotrophic Lateral.MKT was implying a ±7.1% move by 10/21.
    Reply
      • Eric Muathe | Send Message 26 Sep
        Reply
          • bakerbros | Send Message 26 Apr

            nothing but selling $MNOV
            Reply
              • anomaly1 | Send Message 25 Apr

                $MNOV headed to $5
                Reply
                  • anomaly1 | Send Message 20 Apr

                    $MNOV in $5 range when announcement of interim data presentation was made... next ALS trial conclusion in DEC 2017
                    Reply
                      • bakerbros | Send Message 20 Apr

                        $MNOV will it have support at $5 ??? the submarine is diving fast
                        Reply
                          • bakerbros | Send Message 20 Apr

                            CEO announces totally USELESS info to support ALS trial . Useless data = Strong SELL $MNOV
                            Reply
                              • bakerbros | Send Message 18 Apr

                                like I said... shorted $MNOV from $10
                                Reply
                                  • bakerbros | Send Message 18 Apr

                                    MN-166 study was for 1 week stabilization + 1.5 week testing. inconclusive and data limited to subjective questions $MNOV Strong Sell
                                    Reply
                                      • wilkinson99 | Send Message 18 Apr

                                        Premarket Top % Gainers: $CVT 66%, $RXDX 17%, $FCSC 13%, $DRIP 12%, $IMMU 12%, $DWTI 11%, $GASX 10% $BIOC $RUSS $SCO $NM $ERY $ORPN $MNOV
                                        Reply